The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Quantitative screening of advanced glycation endproducts in cellular and extracellular proteins by tandem mass spectrometry
Open accessAbstract
Glycation of proteins forms fructosamines and advanced glycation endproducts. Glycation adducts may be risk markers and risk factors of disease development. We measured the concentrations of the early glycation adduct fructosyl-lysine and 12 advanced glycation endproducts by liquid chromatography with tandem mass spectrometric detection. Underivatized analytes were detected free in physiological fluids and in enzymic hydrolysates of cellular and extracellular proteins. Hydroimidazolones were the most important glycation biomarkers quantitatively; monolysyl adducts (Nε-carboxymethyl-lysine and Nε-1-carboxyethyl-lysine) were found in moderate amounts, and bis(lysyl)imidazolium cross-links and pentosidine in lowest amounts. Quantitative screening showed high levels of advanced glycation endproducts in cellular protein and moderate levels in protein of blood plasma. Glycation adduct accumulation in tissues depended on the particular adduct and tissue type. Low levels of free advanced glycation endproducts were found in blood plasma and levels were 10–100-fold higher in urine. Advanced glycation endproduct residues were increased in blood plasma and at sites of vascular complications development in experimental diabetes; renal glomeruli, retina and peripheral nerve. In clinical uraemia, the concentrations of plasma protein advanced glycation endproduct residues increased 1–7-fold and free adduct concentrations increased up to 50-fold. Comprehensive screening of glycation adducts revealed the relative and quantitative importance of α-oxoaldehyde-derived advanced glycation endproducts in physiological modification of proteins–particularly hydroimidazolones, the efficient renal clearance of free adducts, and the marked increases of glycation adducts in diabetes and uraemia–particularly free advanced glycation endproducts in uraemia. Increased levels of these advanced glycation endproducts were associated with vascular complications in diabetes and uraemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 963
Hammes, H.-P., Du, X., Edelstein, D., Taguchi, T., Matsumura, T., Ju, Q., Lin, J., Bierhaus, A., Nawroth, P., Hannak, D., et al. (2003) · Nature Medicine · doi:10.1038/nm834 · Cited by 785
Tetranitromethane. A Reagent for the Nitration of Tyrosyl Residues in Proteins*
Sokolovsky, M., Riordan, J. F., & Vallee, B. L. (1966) · Biochemistry · doi:10.1021/bi00875a029 · Cited by 637
Glyoxalase System in Clinical Diabetes Mellitus and Correlation with Diabetic Complications
McLellan, A. C., Thornalley, P. J., Benn, J., & Sonksen, P. H. (1994) · Clinical Science · doi:10.1042/cs0870021 · Cited by 557
Self-citationShinohara, M., Thornalley, P. J., Giardino, I., Beisswenger, P., Thorpe, S. R., Onorato, J., & Brownlee, M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119885 · Cited by 513
Self-citationThornalley, P. J. (1998) · PubMed · Cited by 387
Self-citationPrevention of Incipient Diabetic Nephropathy by High-Dose Thiamine and Benfotiamine
Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S., & Thornalley, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.2110 · Cited by 373
Self-citationReactive glycosylation endproducts in diabetic uraemia and treatment of renal failure
Makita, Z., Bucala, R., Rayfield, E. J., Fuh, H., Manogue, K. R., Cerami, A., Viassara, H., Friedman, E. A., Kaufman, A. M., Korbet, S. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92935-1 · Cited by 373
AHMED, N., ARGIROV, O. K., MINHAS, H. S., CORDEIRO, C. A. A., & THORNALLEY, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640001 · Cited by 336
Self-citationPeptide Methionine Sulfoxide Reductase: Structure, Mechanism of Action, and Biological Function
Weissbach, H., Etienne, F., Hoshi, T., Heinemann, S. H., Lowther, W. T., Matthews, B., St. John, G., Nathan, C., & Brot, N. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2664 · Cited by 324
Odani, H., Shinzato, T., Matsumoto, Y., Usami, J., & Maeda, K. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0221 · Cited by 284
Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins
Ohshima, H., Friesen, M., Brouet, I., & Bartsch, H. (1990) · Food and Chemical Toxicology · doi:10.1016/0278-6915(90)90173-k · Cited by 250
Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation
Huggins, T. G., Wells-Knecht, M. C., Detorie, N. A., Baynes, J. W., & Thorpe, S. R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31395-4 · Cited by 223
Differential accumulation of advanced glycation end products in the course of diabetic retinopathy
Hammes, H.-P., Alt, A., Niwa, T., Clausen, J. T., Bretzel, R. G., Brownlee, M., & Schleicher, E. D. (1999) · Diabetologia · doi:10.1007/s001250051221 · Cited by 205
Faist, V., & Erbersdobler, H. F. (2001) · Annals of Nutrition and Metabolism · doi:10.1159/000046699 · Cited by 192
Szwergold, B. S., Howell, S., & Beisswenger, P. J. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2139 · Cited by 172
Advanced glycation end products and the progressive course of renal disease
Heidland, A., Sebekova, K., & Schinzel, R. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27414 · Cited by 168
Ahmed, N., & Thornalley, P. J. (2002) · Biochemical Journal · doi:10.1042/bj3640015 · Cited by 152
Self-citationModulation of Heat-shock Protein 27 (Hsp27) Anti-apoptotic Activity by Methylglyoxal Modification
Sakamoto, H., Mashima, T., Yamamoto, K., & Tsuruo, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207485200 · Cited by 142
Thornalley, P. J., McLellan, A. C., Lo, T. W. C., Benn, J. J., & Sönksen, P. H. (1996) · Clinical Science · doi:10.1042/cs0910575 · Cited by 135
Self-citationGaut, J. P., Byun, J., Tran, H. D., & Heinecke, J. W. (2002) · Analytical Biochemistry · doi:10.1006/abio.2001.5469 · Cited by 135
Isolation and Characterization of Glyoxal−Arginine Modifications
Glomb, M. A., & Lang, G. (2001) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf001082d · Cited by 109
Giulivi, C., & Davies, K. J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010697200 · Cited by 105
Miyata, T., de Strihou, C. V. Y., Imasawa, T., Yoshino, A., Ueda, Y., Ogura, H., Kominami, K., Onogi, H., Inagi, R., Nangaku, M., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00051.x · Cited by 97
Gerner, C., Vejda, S., Gelbmann, D., Bayer, E., Gotzmann, J., Schulte‐Hermann, R., & Mikulits, W. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200026-mcp200 · Cited by 89
Hammes, H., Brownlee, M., Lin, J., Schleicher, E., & Bretzel, R. G. (1999) · Diabetologia · doi:10.1007/s001250051201 · Cited by 84
Finot, P. A., & Mauron, J. (1969) · Helvetica Chimica Acta · doi:10.1002/hlca.19690520609 · Cited by 82
The Proteome Analysis database: a tool for the in silico analysis of whole proteomes
Pruess, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg105 · Cited by 76
8-Iso-Prostaglandin F2α as a Useful Clinical Biomarker of Oxidative Stress in ESRD Patients
Lim, P., Chang, Y.-M., Thien, L.-M., Wang, N.-P., Yang, C.-C., Chen, T.-T., & Hsu, W.-M. (2002) · Blood Purification · doi:10.1159/000066962 · Cited by 65
Zhang, X., Medzihradszky, K. F., Cunningham, J. J., Lee, P., Rognerud, C. L., Ou, C., Harmatz, P., & Witkowska, H. E. (2001) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(01)00196-7 · Cited by 60
Myint, T., Hoshi, S., Ookawara, T., Miyazawa, N., Suzuki, K., & Taniguchi, N. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00067-e · Cited by 59
Poggioli, S., Bakala, H., & Friguet, B. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00145-6 · Cited by 51
Agalou, S., Karachalias, N., Thornalley, P. J., Tucker, B., & Dawnay, A. (2002) · International Congress Series · doi:10.1016/s0531-5131(02)00879-8 · Cited by 22
Self-citation
Cited by
Advanced glycation endproducts in food and their effects on health
Poulsen, M. W., Hedegaard, R. V., Andersen, J. M., de Courten, B., Bügel, S., Nielsen, J., Skibsted, L. H., & Dragsted, L. O. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.06.052 · Cited by 751
Chaudhuri, J., Bains, Y., Guha, S., Kahn, A., Hall, D., Bose, N., Gugliucci, A., & Kapahi, P. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.014 · Cited by 669
“Unfortunately, the trial was discontinued due to side effects (Thornalley, 2003), which has led to reduced enthusiasm in the field that lowering AGEs would be a successful strategy in treating age-related diseases.”
BackgroundSchalkwijk, C. G., & Stehouwer, C. D. A. (2020) · Physiological Reviews · doi:10.1152/physrev.00001.2019 · Cited by 622
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Tomlinson, D. R., & Gardiner, N. J. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2294 · Cited by 564
Metadata
- Authors
- THORNALLEY, P. J., BATTAH, S., AHMED, N., KARACHALIAS, N., AGALOU, S., BABAEI-JADIDI, R., & DAWNAY, A.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2003-11-01
- Volume
- 375
- Issue
- 3
- Pages
- 581-592
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1994051814
- Cited by
- 659
- References
- 35
- FWCI
- 14.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.